This IV drug reference includes more than 350 drug monographs presented in a clinical format. The 2002 edition is updated with hundreds of new drug facts and approximately 10 to 15 new monographs for FDA-approved IV drugs.

This IV drug reference includes more than 350 drug monographs presented in a clinical format. The 2002 edition is updated with hundreds of new drug facts and approximately 10 to 15 new monographs for FDA-approved IV drugs. Each monograph heading includes the drug's generic name, trade name(s), drug category, and pH. Monograph sections include: usual dose; pediatric dose; infant and/or neonatal dose; dose adjustments; dilution, including storage; incompatibilities; rate of administration; actions; indications and uses; contraindications; precautions, including monitor, patient education, maternal/child, and elderly; drug/lab interactions; side effects, including major and minor; and antidote. All drugs are indexed by generic and common trade names, as well as by pharmacologic action. Appendixes offer useful information on handling cytotoxic drugs, alternate choices for infrequently used drugs, FDA pregnancy categories, information for patients receiving immunosuppressive agents, general dilution charts, and National Cancer Institute common toxicity grading criteria.

How to use this book
format and content of intravenous medications
key to abbreviations
important IV therapy facts
IV drugs, A-Z. Appendixes: recommendations for the safe handling of cytotoxic drugs
alternate choices for infrequently used drugs
FDA pregnancy categories
information for patients receiving immunosuppressive agents
general dilution charts
National Cancer Institute common toxicity grading criteria. solution compatibility chart.